Immunological priming potentiates non-viral anti-inflammatory gene therapy treatment of neuropathic pain: Harnessing innate immunity to enhance gene therapy

We recently described a non-viral gene therapy paradigm offering long-term resolution of established neuropathic pain in several animal models. Here, the requirements for long term therapeutic effects are described, and evidence is provided for a mechanism of action based on immunological priming of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sloane, Evan, Langer, Steve, Jekich, Brian, Mahoney, John, Hughes, Travis, Frank, Matthew, Seibert, Whitney, Huberty, Garth, Coats, Benjamen, Harrison, Jackie, Klinman, Dennis, Poole, Steven, Maier, Steven, Johnson, Kirk, Chavez, Ray, Watkins, Linda, Leinwand, Leslie, Milligan, Erin
Formato: Texto
Lenguaje:English
Publicado: 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762489/
https://www.ncbi.nlm.nih.gov/pubmed/19571887
http://dx.doi.org/10.1038/gt.2009.79

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762489/
https://www.ncbi.nlm.nih.gov/pubmed/19571887
http://dx.doi.org/10.1038/gt.2009.79

Ejemplares similares